Hong Kong · Delayed Price · Currency is HKD China Medical System Holdings Company Description
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China.
The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar.
Its products also comprise DanShenTong capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu for treating respiratory diseases; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications.
In addition, the company also offers Elcatonin injection for osteoporosis; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction.
In addition, it is involved in the agriculture and livestock activities. The company was founded in 1995 and is headquartered in North Point, Hong Kong.
China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.
| Country | Hong Kong |
| Founded | 1995 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6,415 |
| CEO | Kong Lam |
Contact Details
Address: Island Place Tower North Point Hong Kong | |
| Phone | 852 2369 7678 |
Stock Details
| Ticker Symbol | 0867 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG211081248 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Kong Lam | Founder, Chairman, Chief Executive Officer and President |
| Yanling Chen | Chief Financial Officer, Vice President and Executive Director |
| Lieyi Ma | General Manager of the Operations and Management Center of the Group |
| Liu Yue | Director of Investor Relations |
| Sanyan Wu | Director of Legal Department and Company Secretary |
| Dr. Huaizheng Peng M.D., Ph.D. | Chief Business Officer |
| Fei Jiang | Chief Investment Officer of Greater China |
| James Patrick Stearns | Chief Investment Officer of Europe and America |